NFGH
NRIX icon

Nan Fung Group Holdings’s Nurix Therapeutics NRIX Stock Holding History

Nan Fung Group Holdings’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,500
Closed -$102K – 46
2023
Q1 		$102K Hold
11,500
– – 0.07% 41
2022
Q4 		$126K Buy
+11,500
New +$139K 0.09% 39

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Nan Fung Group Holdings's NRIX Position: Q2 2023 in Review

Nan Fung Group Holdings sold out of Nurix Therapeutics (NRIX) in Q2 2023, closing a stake of 11,500 shares — an estimated $102K sold.

Nan Fung Group Holdings first reported a position in NRIX in Q4 2022 and held it in 2 quarters. The position peaked at $126K in Q4 2022. 126 funds tracked by Wall St. Rank hold NRIX as of Q2 2023.

  • Nan Fung Group Holdings reported no remaining Nurix Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Nan Fung Group Holdings sold 11,500 Nurix Therapeutics shares in Q2 2023, an estimated $102K.
  • Nan Fung Group Holdings first reported a position in Nurix Therapeutics in Q4 2022 and held it in 2 quarters.
  • Nan Fung Group Holdings's Nurix Therapeutics position peaked at $126K in Q4 2022.
  • 126 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2023.

Based on Nan Fung Group Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.